Cartilage cyclic nucleotide phosphodiesterase: inhibition by anti-inflammatory agents.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D002356:Cartilage / Q000201:enzymology*; D002358:Cartilage, Articular / Q000201:enzymology; D002645:Chickens; D000242:Cyclic AMP; D006152:Cyclic GMP; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D004838:Epiphyses; D006046:Gold / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008528:Mefenamic Acid / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011804:Quinolines / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013442:Sulfinpyrazone / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014316:Tritium
D000893:Anti-Inflammatory Agents; D010726:Phosphodiesterase Inhibitors; D011804:Quinolines; D014316:Tritium; D008528:Mefenamic Acid; D003994:Bucladesine; D006046:Gold; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D010653:Phenylbutazone; D006152:Cyclic GMP; D010113:Oxyphenbutazone; D013442:Sulfinpyrazone; D004298:Dopamine; D007213:Indomethacin; D004837:Epinephrine